Central Garden & Pet
CENT
40.15
+0.13
+0.32%
Central Garden & Pet
US · CENT
#2635 by market cap
Listed 1970
40.15
+0.13
+0.32%
Live - 5344 symbols - heartbeat 138s ago
· 2026-10-08 07:58
Pre-market
40.15
0.00%
After-hours
40.15
0.00%
- Market cap
- 2.51B
- P/E (TTM)i
- 14.87
- P/Bi
- 1.44
- EPSi
- 2.55
- Div yieldi
- 0.00%
- 52W posi
- 63%
Reader sentiment
Are you bullish or bearish on CENT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.70, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -2.23% YoY
Margins
- Gross margin
- 31.87%
- Operating margin
- 7.99%
- Net margin
- 5.20%
Key ratios & quality
- Enterprise valuei
- 2.88B
- PEG ratioi
- 6.50
- Altman Z-Scorei
- 2.70
PEG uses trailing P/E against the 3-year net income growth rate (2.29%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.22B | 2.38B | 2.70B | 3.30B | 3.34B | 3.31B | 3.20B | 3.13B |
| Gross profit | 675.38M | 704.04M | 796.56M | 970.90M | 992.31M | 946.84M | 943.74M | 997.34M |
| Selling & admin expenses | 508.04M | 551.97M | 598.58M | 716.41M | 732.27M | 736.20M | 758.35M | 747.29M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 167.34M | 152.07M | 197.98M | 254.50M | 260.04M | 210.65M | 185.39M | 250.04M |
| Pretax profit | 127.43M | 119.25M | 153.74M | 194.81M | 198.91M | 162.45M | 142.43M | 216.75M |
| Tax | 3.31M | 26.60M | 32.22M | 42.04M | 46.23M | 36.35M | 33.11M | 52.79M |
| Net profit | 124.12M | 92.65M | 121.52M | 152.77M | 152.67M | 126.10M | 109.31M | 163.96M |
| Basic EPS | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 3 |
| Diluted EPS | 1.86 | 1.29 | 1.76 | 2.20 | 2.24 | 1.88 | 1.62 | 2.55 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 833.54M | 960.91M | 678.18M | 617.37M | 906.15M | 882.36M |
| Gross profit | 273.08M | 332.01M | 196.54M | 190.61M | 299.56M | 316.92M |
| Selling & admin expenses | 179.76M | 196.88M | 202.94M | 174.08M | 185.63M | 191.07M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 93.32M | 135.13M | -6.40M | 16.53M | 113.94M | 125.84M |
| Pretax profit | 84.71M | 127.35M | -13.86M | 8.95M | 104.50M | 119.59M |
| Tax | 19.90M | 31.94M | -3.42M | 2.09M | 24.53M | 29.60M |
| Net profit | 64.81M | 95.41M | -10.44M | 6.86M | 79.97M | 89.99M |
| Basic EPS | 1 | 2 | 0 | 0 | 1 | 1 |
| Diluted EPS | 0.98 | 1.52 | -0.16 | 0.11 | 1.28 | 1.45 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.22B | 1.31B | 1.53B | 1.54B | 1.55B | 1.71B | 1.89B | 1.98B |
| Cash & ST investments | 482.11M | 497.75M | 652.71M | 426.42M | 177.44M | 488.73M | 753.55M | 882.49M |
| Inventory | 427.82M | 466.20M | 439.62M | 685.24M | 938.00M | 838.19M | 757.94M | 722.11M |
| Total assets | 1.91B | 2.03B | 2.34B | 3.12B | 3.28B | 3.38B | 3.55B | 3.63B |
| Total current liabilities | 212.96M | 278.53M | 440.26M | 522.32M | 465.89M | 457.99M | 515.38M | 538.76M |
| Short-term debt | 122.00K | 113.00K | 33.59M | 41.81M | 48.43M | 50.84M | 57.55M | 56.93M |
| Long-term debt | 692.03M | 693.04M | 693.96M | 1.18B | 1.19B | 1.19B | 1.19B | 1.19B |
| Total liabilities | 954,375,000.00 | 1,028,843,000.00 | 1,261,690,000.00 | 1,893,139,000.00 | 1,947,290,000.00 | 1,925,835,000.00 | 1,995,894,000.00 | 2,040,710,000.00 |
| Total equity | 952.83M | 996.18M | 1.08B | 1.22B | 1.33B | 1.45B | 1.56B | 1.58B |
| Retained earnings | 362.92M | 421.74M | 510.78M | 646.08M | 755.25M | 859.37M | 959.51M | 1.02B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.98B | 2.00B | 1.98B | 1.97B | 2.09B | 2.13B |
| Cash & ST investments | 516.68M | 713.05M | 882.49M | 721.15M | 653.24M | 996.71M |
| Inventory | 824.28M | 718.27M | 722.11M | 836.27M | 782.33M | 631.65M |
| Total assets | 3.63B | 3.66B | 3.63B | 3.64B | 3.75B | 3.79B |
| Total current liabilities | 597.65M | 562.18M | 538.76M | 574.00M | 605.16M | 563.71M |
| Short-term debt | 58.57M | 56.86M | 56.93M | 52.91M | 51.61M | 50.74M |
| Long-term debt | 1.19B | 1.19B | 1.19B | 1.19B | 1.19B | 1.19B |
| Total liabilities | 2,086,213,000.00 | 2,066,792,000.00 | 2,040,710,000.00 | 2,067,467,000.00 | 2,093,187,000.00 | 2,043,052,000.00 |
| Total equity | 1.54B | 1.59B | 1.58B | 1.58B | 1.65B | 1.75B |
| Retained earnings | 969.72M | 1.02B | 1.02B | 1.01B | 1.09B | 1.18B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 114.11M | 204.97M | 264.27M | 250.84M | -34.03M | 381.63M | 394.89M | 332.51M |
| Depreciation & amortization | 47.20M | 50.83M | 55.36M | 74.73M | 80.95M | 87.70M | 90.81M | 84.89M |
| Free cash flow | 76.27M | 173.40M | 221.22M | 170.51M | -149.24M | 327.67M | 351.76M | 291.09M |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | -- | -- | -- |
| Stock buybacks / issuance | 181.83M | -62.97M | -59.13M | -27.89M | -62.29M | -37.16M | -24.07M | -155.07M |
| Ending cash balance | 493.01M | 510.70M | 666.40M | 439.52M | 192.18M | 502.87M | 768.40M | 898.43M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -46.86M | 265.48M | 182.73M | -70.22M | -49.64M | 327.46M |
| Depreciation & amortization | 20.65M | 21.48M | 20.83M | 20.66M | 20.69M | 19.63M |
| Free cash flow | -57.52M | 251.66M | 171.89M | -81.03M | -60.09M | 314.87M |
| Dividends paid | 0 | 0 | -- | 0 | 0 | 0 |
| Stock buybacks / issuance | -44.21M | -56.50M | -332.00K | -20.01M | -7.86M | -951.00K |
| Ending cash balance | 531.34M | 727.74M | 898.43M | 737.24M | 669.41M | 1.01B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 15.56 | 9.52 | 11.64 | 13.20 | 11.91 | 9.02 | 7.18 | 10.38 |
| ROA %i | 7.69 | 4.72 | 5.53 | 5.56 | 4.76 | 3.77 | 3.12 | 4.54 |
| ROIC %i | 11.86 | 7.11 | 8.51 | 8.83 | 7.42 | 5.93 | 4.73 | 6.26 |
| 5-year avg ROE %i | 9.11 | 10.64 | 11.68 | 12.64 | 12.37 | 11.06 | 10.59 | 10.34 |
| EBIT margin %i | 7.52 | 6.79 | 7.34 | 7.67 | 7.70 | 6.63 | 6.25 | 8.77 |
| FCF / sales %i | 3.44 | 7.28 | 8.21 | 5.16 | -- | 9.90 | 10.99 | 9.30 |
| Current ratioi | 5.72 | 4.69 | 3.46 | 2.96 | 3.34 | 3.73 | 3.66 | 3.67 |
| Quick ratioi | 3.56 | 2.86 | 2.37 | 1.55 | 1.19 | 1.79 | 2.10 | 2.24 |
| Debt / assetsi | 36.29 | 34.23 | 34.80 | 43.53 | 42.12 | 40.68 | 39.97 | 39.73 |
| LT debt / equityi | 72.66 | 69.58 | 72.48 | 107.57 | 100.02 | 91.20 | 87.61 | 87.38 |
| Interest coveragei | 4.25 | 3.80 | 4.49 | 4.32 | 4.41 | 3.85 | 3.48 | 4.76 |
| Revenue CAGR (3Y) %i | 10.30 | 9.22 | 9.47 | 14.25 | 11.90 | 7.09 | -1.05 | -2.14 |
| Net income CAGR (3Y) %i | 56.94 | 27.74 | 15.25 | 7.08 | 17.92 | 1.35 | -10.72 | 2.29 |
| FCF CAGR (3Y) %i | 5.25 | 11.88 | 46.99 | 30.76 | -- | 13.99 | 27.30 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 8.07 | 8.71 | 10.38 | 10.06 | 10.74 | 9.98 |
| ROA %i | 3.44 | 3.81 | 4.54 | 4.34 | 4.65 | 4.47 |
| ROIC %i | 5.09 | 5.42 | 6.26 | 6.09 | 6.50 | 6.16 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.03 | 7.79 | 8.77 | 8.57 | 8.99 | 8.96 |
| FCF / sales %i | 10.55 | 10.01 | 9.30 | 9.22 | 8.93 | 11.21 |
| Current ratioi | 3.31 | 3.56 | 3.67 | 3.42 | 3.45 | 3.79 |
| Quick ratioi | 1.83 | 2.20 | 2.24 | 1.88 | 2.08 | 2.58 |
| Debt / assetsi | 39.26 | 39.27 | 39.73 | 39.14 | 37.87 | 37.17 |
| LT debt / equityi | 88.63 | 86.86 | 87.38 | 87.16 | 82.78 | 77.78 |
| Interest coveragei | 3.84 | 4.23 | 4.76 | 4.59 | 4.96 | 4.83 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Garden is the largest reported line at 54.61% of revenue, across 2 reported segments.
- Pet follows at 45.39%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Garden54.61%
Pet45.39%
Quote time 2026-10-08 07:58:30 · For reference only, not investment advice and not tailored to your situation.